Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Galena Biopharma Inc    GALE   US3632561086

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Nasdaq
06/29/2015 06/30/2015 07/01/2015 07/02/2015 Date
1.66(c) 1.7(c) 1.73(c) 1.68(c) 1.68 Last
2 388 964 2 025 950 1 501 284 1 241 815 1 241 815 Volume
-5.68% +2.41% +1.76% -2.89% -2.89% Change
More quotes
Financials ($)
Sales 2015 16,1 M
EBIT 2015 -44,6 M
Net income 2015 -46,5 M
Debt 2015 -
Yield 2015 -
Sales 2016 27,5 M
EBIT 2016 -35,6 M
Net income 2016 -34,5 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 16,9x
Capi. / Sales 2016 9,90x
Capitalization 272 M
More Financials
Company
Galena Biopharma, Inc. is a biotechnology company focused on discovering, developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care.Its development portfolio ranges from mid to late stage clinical assets which include... 
Sector
Pharmaceuticals
Calendar
08/17Earnings Release
More about the company
Surperformance© ratings of Galena Biopharma Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on GALENA BIOPHARMA INC
06/24 GALENA BIOPHARMA : Change in Directors or Principal Officers, Other Events (form..
06/15 Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Phase 2 Da..
06/08 GALENA BIOPHARMA : GALE) is Trading Higher on Unusual Volume for June 08
05/29 GALENA BIOPHARMA : to Present at the Sachs Immuno-Oncology BD&L and Investment F..
05/28 Galena Biopharma to Present at the Sachs Immuno-Oncology BD&L and Investment ..
05/27 GALENA BIOPHARMA : rises on cancer therapy study
05/27 Galena Biopharma Announces Publication of Two Abstracts at the 2015 American ..
05/23 GALENA BIOPHARMA : to Present GALE-401 (Anagrelide Controlled Release) Phase 2 C..
More news
Sector news : Pharmaceuticals - NEC
04:49a BAYER : MaterialScience - Creative material solutions for future automotive conc..
07/05 PERRIGO : BRIEF: Vigodman: If Mylan shareholders vote to buy Perrigo we'll withd..
07/05 NOVARTIS : 'More efforts needed worldwide to prevent eye diseases'
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
06/15 Galena's anagrelide shows encouraging results in Phase 2 study
06/08 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
05/27 Galena up on ASCO abstracts on NeuVax and GALE-301
05/27 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
05/07 Galena Biopharma's (GALE) CEO Mark Schwartz on Q1 2015 Results - Earnings Cal..


Comments 
Advertisement
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | GALE | US3632561086 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions